JP2013513360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013513360A5 JP2013513360A5 JP2012542402A JP2012542402A JP2013513360A5 JP 2013513360 A5 JP2013513360 A5 JP 2013513360A5 JP 2012542402 A JP2012542402 A JP 2012542402A JP 2012542402 A JP2012542402 A JP 2012542402A JP 2013513360 A5 JP2013513360 A5 JP 2013513360A5
- Authority
- JP
- Japan
- Prior art keywords
- oligonucleotide
- amino group
- target sequence
- sequence
- nucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091034117 Oligonucleotide Proteins 0.000 claims 36
- 125000003729 nucleotide group Chemical group 0.000 claims 25
- 239000002773 nucleotide Substances 0.000 claims 24
- 125000003277 amino group Chemical group 0.000 claims 23
- 230000000295 complement effect Effects 0.000 claims 19
- 238000000034 method Methods 0.000 claims 12
- 108020004707 nucleic acids Proteins 0.000 claims 12
- 150000007523 nucleic acids Chemical class 0.000 claims 12
- 102000039446 nucleic acids Human genes 0.000 claims 12
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims 8
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims 8
- 238000003752 polymerase chain reaction Methods 0.000 claims 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 7
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Chemical group O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 claims 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims 4
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims 4
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Chemical group O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 claims 4
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims 4
- 229960005305 adenosine Drugs 0.000 claims 4
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical group O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 claims 4
- 229940029575 guanosine Drugs 0.000 claims 4
- 238000009396 hybridization Methods 0.000 claims 4
- 108700028369 Alleles Proteins 0.000 claims 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 3
- 230000003321 amplification Effects 0.000 claims 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims 2
- 239000002777 nucleoside Substances 0.000 claims 2
- -1 nucleoside triphosphate Chemical class 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 235000011178 triphosphate Nutrition 0.000 claims 2
- 239000001226 triphosphate Substances 0.000 claims 2
- WWOZGLRRDHCCGH-UHFFFAOYSA-N 4-amino-4-benzyl-1,3-dihydropyrimidin-2-one Chemical compound C=1C=CC=CC=1CC1(N)NC(=O)NC=C1 WWOZGLRRDHCCGH-UHFFFAOYSA-N 0.000 claims 1
- RYDDEYJZMHLIHD-UHFFFAOYSA-N 6-[(4-tert-butylphenyl)methyl]purin-6-amine Chemical compound C(C)(C)(C)C1=CC=C(CC2(C3=NC=NC3=NC=N2)N)C=C1 RYDDEYJZMHLIHD-UHFFFAOYSA-N 0.000 claims 1
- 101100381977 Homo sapiens BRAF gene Proteins 0.000 claims 1
- 101000851181 Homo sapiens Epidermal growth factor receptor Proteins 0.000 claims 1
- 101100086477 Homo sapiens KRAS gene Proteins 0.000 claims 1
- 101000605639 Homo sapiens Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Proteins 0.000 claims 1
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims 1
- 101710163270 Nuclease Proteins 0.000 claims 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 claims 1
- 108010006785 Taq Polymerase Proteins 0.000 claims 1
- 241000204666 Thermotoga maritima Species 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 1
- 102000050152 human BRAF Human genes 0.000 claims 1
- 102000057995 human PIK3CA Human genes 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28569009P | 2009-12-11 | 2009-12-11 | |
| US61/285,690 | 2009-12-11 | ||
| PCT/EP2010/007560 WO2011069677A1 (en) | 2009-12-11 | 2010-12-10 | Allele-specific amplification of nucleic acids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015196657A Division JP2016013137A (ja) | 2009-12-11 | 2015-10-02 | 核酸の対立遺伝子特異的増幅 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013513360A JP2013513360A (ja) | 2013-04-22 |
| JP2013513360A5 true JP2013513360A5 (OSRAM) | 2013-07-11 |
| JP5886755B2 JP5886755B2 (ja) | 2016-03-16 |
Family
ID=43531218
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012542402A Active JP5886755B2 (ja) | 2009-12-11 | 2010-12-10 | 核酸の対立遺伝子特異的増幅 |
| JP2015196657A Pending JP2016013137A (ja) | 2009-12-11 | 2015-10-02 | 核酸の対立遺伝子特異的増幅 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015196657A Pending JP2016013137A (ja) | 2009-12-11 | 2015-10-02 | 核酸の対立遺伝子特異的増幅 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9238832B2 (OSRAM) |
| EP (1) | EP2510117B1 (OSRAM) |
| JP (2) | JP5886755B2 (OSRAM) |
| CN (2) | CN106987624A (OSRAM) |
| CA (1) | CA2781984C (OSRAM) |
| ES (1) | ES2530273T3 (OSRAM) |
| WO (1) | WO2011069677A1 (OSRAM) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103748236B (zh) | 2011-04-15 | 2018-12-25 | 约翰·霍普金斯大学 | 安全测序系统 |
| WO2013022807A1 (en) * | 2011-08-05 | 2013-02-14 | Unitaq Bio | Methods and compositions for detection of nucleic acids using 5'-nuclease cleavage and amplification |
| KR20140064971A (ko) | 2011-09-19 | 2014-05-28 | 제넨테크, 인크. | c-met 길항제 및 B-raf 길항제를 포함하는 조합 치료 |
| US9738935B2 (en) * | 2011-11-10 | 2017-08-22 | Roche Molecular Systems, Inc. | Complex mutations in the epidermal growth factor receptor kinase domain |
| PL2912468T3 (pl) | 2012-10-29 | 2019-04-30 | Univ Johns Hopkins | Test papanicolaou pod kątem raka jajnika i endometrium |
| US9382581B2 (en) * | 2012-12-13 | 2016-07-05 | Roche Molecular Systems, Inc. | Primers with modified phosphate and base in allele-specific PCR |
| CA2899712C (en) * | 2013-03-13 | 2021-01-05 | F. Hoffmann-La Roche Ag | Methods and compositions for detecting mutations in the human pi3kca (pik3ca) gene |
| CN103911445B (zh) * | 2014-03-20 | 2015-08-12 | 上海科亦生物科技有限公司 | 一种as-pcr引物设计方法、基因多态性检测方法及试剂盒 |
| CN104845967B (zh) * | 2015-04-15 | 2020-12-11 | 苏州新海生物科技股份有限公司 | 寡聚核苷酸片段及使用其的选择性扩增目标核酸序列变异体的方法及应用 |
| KR101756875B1 (ko) * | 2015-05-28 | 2017-07-11 | 에스디 바이오센서 주식회사 | 상보적 염기서열과 미스-매치된 염기서열 그리고 reporter와 quencher를 포함하는 이중 기능성 올리고뉴클레오타이드 및 이를 이용한 핵산 증폭 및 측정 방법 |
| US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
| EP3916107B1 (en) * | 2016-02-17 | 2023-04-05 | President and Fellows of Harvard College | Molecular programming tools |
| JP2018164421A (ja) * | 2017-03-28 | 2018-10-25 | 東洋紡株式会社 | 核酸増幅方法 |
| MX2020001575A (es) | 2017-08-07 | 2020-11-18 | Univ Johns Hopkins | Materiales y métodos para evaluar y tratar el cáncer. |
| WO2019099420A1 (en) * | 2017-11-15 | 2019-05-23 | Yan Wang | A method for detecting multiple dna mutations and copy number variations |
| US20220073977A1 (en) | 2020-02-14 | 2022-03-10 | The Johns Hopkins University | Methods and materials for assessing nucleic acids |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DE3529478A1 (de) | 1985-08-16 | 1987-02-19 | Boehringer Mannheim Gmbh | 7-desaza-2'desoxyguanosin-nukleotide, verfahren zu deren herstellung und deren verwendung zur nukleinsaeure-sequenzierung |
| US5795762A (en) | 1986-08-22 | 1998-08-18 | Roche Molecular Systems, Inc. | 5' to 3' exonuclease mutations of thermostable DNA polymerases |
| IE61148B1 (en) | 1988-03-10 | 1994-10-05 | Ici Plc | Method of detecting nucleotide sequences |
| US5521301A (en) | 1988-12-12 | 1996-05-28 | City Of Hope | Genotyping of multiple allele systems |
| US5639611A (en) | 1988-12-12 | 1997-06-17 | City Of Hope | Allele specific polymerase chain reaction |
| US5137806A (en) | 1989-12-11 | 1992-08-11 | Board Of Regents, The University Of Texas System | Methods and compositions for the detection of sequences in selected DNA molecules |
| WO1991012342A1 (en) | 1990-02-16 | 1991-08-22 | F. Hoffmann-La Roche Ag | Improvements in the specificity and convenience of the polymerase chain reaction |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| JPH04234422A (ja) | 1990-10-31 | 1992-08-24 | Internatl Business Mach Corp <Ibm> | 二重硬化エポキシバックシール処方物 |
| US5840867A (en) | 1991-02-21 | 1998-11-24 | Gilead Sciences, Inc. | Aptamer analogs specific for biomolecules |
| US5644048A (en) | 1992-01-10 | 1997-07-01 | Isis Pharmaceuticals, Inc. | Process for preparing phosphorothioate oligonucleotides |
| DE4234086A1 (de) | 1992-02-05 | 1993-08-12 | Diagen Inst Molekularbio | Verfahren zur bestimmung von in vitro amplifizierten nukleinsaeuresequenzen |
| US5338671A (en) | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
| US5773258A (en) | 1995-08-25 | 1998-06-30 | Roche Molecular Systems, Inc. | Nucleic acid amplification using a reversibly inactivated thermostable enzyme |
| PT912766E (pt) | 1996-06-04 | 2009-07-16 | Univ Utah Res Found | Monitorização da hibridização durante a pcr |
| ATE280177T1 (de) | 1997-03-20 | 2004-11-15 | Hoffmann La Roche | Modifizierte primer |
| ATE236997T1 (de) | 1998-07-21 | 2003-04-15 | Keygene Nv | Verbesserte primer zur aflp amplifizierung |
| US6200757B1 (en) | 1999-01-19 | 2001-03-13 | Dade Behring Inc. | Method for controlling the extension of an oligonucleotide |
| EP1088891B1 (en) * | 1999-09-28 | 2005-01-12 | Roche Diagnostics GmbH | Thermostable enzyme promoting the fidelity of thermostable DNA polymerases - for improvement of nucleic acid synthesis and amplification in vitro |
| JP3937136B2 (ja) | 1999-12-10 | 2007-06-27 | 東洋紡績株式会社 | 塩基多型の検出方法 |
| US7582420B2 (en) * | 2001-07-12 | 2009-09-01 | Illumina, Inc. | Multiplex nucleic acid reactions |
| EP1367136A4 (en) | 2001-02-15 | 2005-01-12 | Takara Bio Inc | METHOD FOR DETECTING NUCLEOTIDE POLYMORPHISM |
| AU2003229549A1 (en) | 2002-02-26 | 2003-09-09 | Roche Diagnostics Gmbh | Improved method for allele-specific pcr |
| US7148049B2 (en) | 2002-04-02 | 2006-12-12 | Roche Molecular Systems, Inc. | Thermostable or thermoactive DNA polymerase molecules with attenuated 3′-5′ exonuclease activity |
| US20050019918A1 (en) * | 2003-06-03 | 2005-01-27 | Hidetoshi Sumimoto | Treatment of cancer by inhibiting BRAF expression |
| US7408051B2 (en) | 2004-04-14 | 2008-08-05 | Applera Corporation | Modified oligonucleotides and applications thereof |
| US20060141497A1 (en) * | 2004-10-22 | 2006-06-29 | Finkelstein Sydney D | Molecular analysis of cellular fluid and liquid cytology specimens for clinical diagnosis, characterization, and integration with microscopic pathology evaluation |
| US7442507B2 (en) | 2005-01-24 | 2008-10-28 | New York University School Of Medicine | Methods for detecting circulating mutant BRAF DNA |
| JP3859687B1 (ja) | 2005-11-21 | 2006-12-20 | 松下電器産業株式会社 | Ｄｎａが有する標的塩基を判別する方法 |
| ES2700606T3 (es) | 2006-04-28 | 2019-02-18 | Igor Kutyavin | Uso de trifosfatos de desoxinucleósidos modificados en sus bases para mejorar la detección de ácidos nucleicos |
| JP2009077712A (ja) * | 2007-09-11 | 2009-04-16 | F Hoffmann La Roche Ag | Ｂ−Ｒａｆキナーゼ阻害剤に対する感受性についての診断試験 |
| JP5624044B2 (ja) | 2008-10-20 | 2014-11-12 | エフ．ホフマン−ラ ロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | 改善されたアレル−特異的増幅 |
| EP2418515A1 (en) | 2010-07-21 | 2012-02-15 | Astrium GmbH | Integrity method for differential corrections |
-
2010
- 2010-12-08 US US12/962,861 patent/US9238832B2/en active Active
- 2010-12-10 CA CA2781984A patent/CA2781984C/en active Active
- 2010-12-10 ES ES10795240.0T patent/ES2530273T3/es active Active
- 2010-12-10 WO PCT/EP2010/007560 patent/WO2011069677A1/en not_active Ceased
- 2010-12-10 EP EP10795240.0A patent/EP2510117B1/en active Active
- 2010-12-10 CN CN201710169202.2A patent/CN106987624A/zh active Pending
- 2010-12-10 CN CN201080055770.6A patent/CN102656278A/zh active Pending
- 2010-12-10 JP JP2012542402A patent/JP5886755B2/ja active Active
-
2015
- 2015-10-02 JP JP2015196657A patent/JP2016013137A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013513360A5 (OSRAM) | ||
| JP6434932B2 (ja) | トーホールドプライマーデュプレックスの組成物およびその使用方法 | |
| US20070048758A1 (en) | Improved primer-based amplification methods | |
| CN101517091B (zh) | 用于核酸扩增的化学修饰的寡核苷酸引物 | |
| JP5886755B2 (ja) | 核酸の対立遺伝子特異的増幅 | |
| CN102301011B (zh) | 对小rna进行定量的方法 | |
| JP2012505641A5 (OSRAM) | ||
| JP2011502502A5 (OSRAM) | ||
| JP6997784B2 (ja) | 核酸の増幅方法および該方法を実施するためのキット | |
| JP2014014371A5 (OSRAM) | ||
| JP2012531202A5 (OSRAM) | ||
| FI3564394T3 (fi) | Menetelmä alukkeen polynukleotidien kirjastojen valmistamiseksi | |
| JP2016521548A5 (OSRAM) | ||
| JP2012514451A5 (OSRAM) | ||
| JP2009529337A5 (OSRAM) | ||
| JP2017526347A5 (OSRAM) | ||
| JP2008029333A (ja) | 新規遺伝子増幅法に用いられるプライマー | |
| JP2015536685A (ja) | 対立遺伝子特異的ｐｃｒにおける修飾されたリン酸及び修飾された塩基を有するプライマー | |
| US10801056B2 (en) | Kit and method for detection of microRNA | |
| JP2014527823A5 (OSRAM) | ||
| ES2656961T3 (es) | Uso de G-Clamp para mejorar la PCR específica de alelo | |
| JP6964900B2 (ja) | 核酸増幅の特異的抑制方法 | |
| JPWO2020077227A5 (OSRAM) | ||
| JP2013513359A5 (OSRAM) | ||
| JP5831093B2 (ja) | Ｃ型慢性肝炎に対する治療効果を予測するためのプローブ |